Dublin, Oct. 30, 2019 (GLOBE NEWSWIRE) -- The "Primary Cells - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.
The Primary Cells market worldwide is projected to grow by US$524 Million, driven by a compounded growth of 8.2%
Human Primary Cells, one of the segments analyzed and sized in this study, displays the potential to grow at over 8.6%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$991 Million by the year 2025, Human Primary Cells will bring in healthy gains adding significant momentum to global growth.
Representing the developed world, the United States will maintain a 9.4% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$23.7 Million to the region's size and clout in the next 5 to 6 years. Over US$24.5 Million worth of projected demand in the region will come from the rest of the European markets.
In Japan, Human Primary Cells will reach a market size of US$72.1 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 7.8% over the next couple of years and add approximately US$89.7 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.
Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio.
Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.
Competitors identified in this market include:
- Allcells LLC
- American Type Culture Collection (ATCC)
- Axol Bioscience Ltd.
- Cell Biologics, Inc.
- Lonza Group AG
- Merck KgaA
- Promocell GmbH
- Thermo Fisher Scientific, Inc.
- Zenbio, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/37u0q6